ESC 365 - Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position

ESC Professional Premium Access

Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position

Session: Walking the line between bleeding and thrombosis in valvular heart disease

Topic: Prosthetic Heart Valves

Speaker: Mrs E. Skogseid (Uppsala, SE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Mrs Ebba-Louise Skogseid

Uppsala University, Uppsala (Sweden)

1 presentation

0 follower

6 more presentations in this session

Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF

Speaker: Professor N. van Mieghem (Rotterdam, NL)

Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)

Speaker: Doctor C. Hohmann (Cologne, DE)

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr J. Lehto (Turku, FI)

Efficacy of aortic valve replacement on Heyde syndrome-related acquired von Willebrand syndrome and gastrointestinal bleeding: a systematic review and meta-analysis

Speaker: Mr M. Rooijakkers (Nijmegen, NL)

Access the full session

Walking the line between bleeding and thrombosis in valvular heart disease

Speakers: Mrs E. Skogseid, Doctor B. Al-Kassou, Professor N. van Mieghem, Doctor C. Hohmann, Mr J. Lehto...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by